NDC 68788-8685
Clindamycin Hydrochloride 300 mg capsule
On the label: Preferred Pharmaceuticals, Inc... It's repackaged: Preferred Pharmaceuticals, Inc.. rebottles it from Glenmark Pharmaceuticals Inc., USA's NDC 68462-144.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Dhar, India | Makes it and tests it | Serious problems, FDA actionFeb 14, 2025 · 8 inspections, 1 with FDA action |
Repackaging site
- Preferred Pharmaceuticals Inc., Anaheim, CA, United States · repackages it
Recalls
- Apr 18, 2025 · Class II · Preferred Pharmaceuticals, Inc.
cGMP Deviations
Lots: Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026. - Mar 13, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lot # 17241278, exp. date Jul-26 17241297, exp. date Jul-26 17241304, exp. date Jul-26 17241315, exp. date Jul-26 17241327, exp. date Jul-26
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Clindamycin: every company that makes it
- Form
- capsule, oral
- Strength
- 300 mg
- Approval
- ANDA ANDA216957
- On the market since
- Jun 1, 2024
- Package NDCs
68788-8685-168788-8685-268788-8685-368788-8685-468788-8685-568788-8685-668788-8685-8- Official label
- DailyMed (National Library of Medicine), updated Mar 30, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?